Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000712994 | SCV000843555 | uncertain significance | not provided | 2024-08-26 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000765118 | SCV000896340 | uncertain significance | Charlevoix-Saguenay spastic ataxia | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001034278 | SCV001197616 | likely benign | Spastic paraplegia | 2024-12-02 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000712994 | SCV001713615 | uncertain significance | not provided | 2019-09-02 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000765118 | SCV002026592 | uncertain significance | Charlevoix-Saguenay spastic ataxia | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV000765118 | SCV006058597 | uncertain significance | Charlevoix-Saguenay spastic ataxia | 2022-02-18 | criteria provided, single submitter | research | |
Natera, |
RCV000765118 | SCV001455920 | likely benign | Charlevoix-Saguenay spastic ataxia | 2020-06-16 | no assertion criteria provided | clinical testing |